The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer

Objective: The therapeutic effects of the checkpoint kinase 1 (CHK1)-targeted inhibition in tumor therapy have been confirmed, but how to choose an effective application method in breast cancer with heterogeneous molecular characteristics has remained unclear. Methods: We evaluated the status of CHK...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wei, Huang, Minghua, Guo, Jia, Zhang, Huiting, Wang, Depeng, Liu, Tiantian, Liu, Haiting, Chen, Shiming, Gao, Peng, Mu, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085233/
https://www.ncbi.nlm.nih.gov/pubmed/32210727
http://dx.doi.org/10.7150/ijbs.41627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085233/
https://www.ncbi.nlm.nih.gov/pubmed/32210727
http://dx.doi.org/10.7150/ijbs.41627

Ejemplares similares